Recent Quotes
My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeuroOne Medical Technologies Corporation - Common Stock (NQ:NMTC)

0.7153 +0.0353 (+5.19%)
Streaming Delayed Price Updated: 9:56 AM EST, Feb 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 21,163
Open 0.6800
Bid (Size) 0.6930 (500)
Ask (Size) 0.7209 (500)
Prev. Close 0.6800
Today's Range 0.6800 - 0.7153
52wk Range 0.3954 - 1.180
Shares Outstanding 12,000,585
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
NeuroOne (NMTC) Q1 2026 Earnings Call Transcript ↗
NeuroOne (NMTC) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
NeuroOne Reports Fiscal Q1 2026 Financial Results; Expects Product Revenue of At Least $10.5 Million in Fiscal Year 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property

Performance

YTD
-16.1%
-16.1%
1 Month
-19.5%
-19.5%
3 Month
+7.7%
+7.7%
6 Month
-8.4%
-8.4%
1 Year
-36.7%
-36.7%

More News

Read More
NeuroOne Reports Fiscal Q1 2026 Financial Results; Expects Product Revenue of At Least $10.5 Million in Fiscal Year 2026
Via TheNewswire.com
Topics Intellectual Property
News headline image
NeuroOne(R) to Report First Quarter Fiscal Year 2026 Financial Results on Tuesday, February 17 at 8:30 a.m. Eastern Time
Via NewMediaWire
Topics Earnings
NeuroOne(R) Appoints Jason Mills to the Board of Directors
Via TheNewswire.com
NeuroOne(R) to Report First Quarter Fiscal Year 2026 Financial Results on Tuesday, February 17 at 8:30 a.m. Eastern Time
Via TheNewswire.com
Topics Earnings
News headline image
NeuroOne(R) Appoints Jason Mills to the Board of Directors
Via NewMediaWire
News headline image
NeuroOne Reports Strong Fourth Quarter Fiscal 2025 Financial Results With Product Revenue Growth of 907% to $2.7 Million and 55.8% Gross Margin & Total Revenue Growth of 163% to $9.1 Million for Fiscal Year 2025
Via NewMediaWire
Topics Intellectual Property
NeuroOne Reports Strong Fourth Quarter Fiscal 2025 Financial Results With Product Revenue Growth of 907% to $2.7 Million and 55.8% Gross Margin & Total Revenue Growth of 163% to $9.1 Million for Fiscal Year 2025
Via TheNewswire.com
Topics Intellectual Property
News headline image
Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
Via Chartmill
NeuroOne(R) to Report Fourth Quarter and Fiscal Year 2025 Financial Results on Wednesday, December 17th at 8:30 a.m. Eastern Time
Via TheNewswire.com
Topics Artificial Intelligence Earnings
News headline image
NeuroOne(R) to Report Fourth Quarter and Fiscal Year 2025 Financial Results on Wednesday, December 17th at 8:30 a.m. Eastern Time
Via NewMediaWire
Topics Artificial Intelligence Earnings
News headline image
NeuroOne(R) Announces Initial Successful Cases Completed With OneRF(R) Trigeminal Nerve Ablation System at the University Hospitals in Cleveland
Via NewMediaWire
NeuroOne(R) Announces Initial Successful Cases Completed With OneRF(R) Trigeminal Nerve Ablation System at the University Hospitals in Cleveland
Via TheNewswire.com
News headline image
NeuroOne(R) Announces Upcoming Industry Conference Participation
Via NewMediaWire
Topics Artificial Intelligence
NeuroOne(R) Announces Upcoming Industry Conference Participation
Via TheNewswire.com
Topics Artificial Intelligence
News headline image
Nasdaq's Lifeline: NeuroOne Medical Technologies Secures 180-Day Extension Amidst Delisting Fears
Via MarketMinute
News headline image
NeuroOne(R) Receives 180-Day Extension From Nasdaq to Regain Minimum Bid Price Compliance
Via NewMediaWire
NeuroOne(R) Receives 180-Day Extension From Nasdaq to Regain Minimum Bid Price Compliance
Via TheNewswire.com
NeuroOne Promotes Emily Johns to Chief Administrative Officer
Via TheNewswire.com
Topics Artificial Intelligence
News headline image
NeuroOne Promotes Emily Johns to Chief Administrative Officer
Via NewMediaWire
Topics Artificial Intelligence
News headline image
NeuroOne(R) Bolsters Patent Portfolio With Recent Decisions From Both the U.S. Patent & Trademark Office and European Patent Office
Via NewMediaWire
Topics Intellectual Property
NeuroOne(R) Bolsters Patent Portfolio With Recent Decisions From Both the U.S. Patent & Trademark Office and European Patent Office
Via TheNewswire.com
Topics Intellectual Property
News headline image
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
NeuroOne Announces Preliminary Unaudited Product Revenue Growth of 163% to Record $9.1 Million, Invitation to Join Virtual Investor Webinar Tomorrow at 8:30 am EST
Via TheNewswire.com

Frequently Asked Questions

Is NeuroOne Medical Technologies Corporation - Common Stock publicly traded?
Yes, NeuroOne Medical Technologies Corporation - Common Stock is publicly traded.
What exchange does NeuroOne Medical Technologies Corporation - Common Stock trade on?
NeuroOne Medical Technologies Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for NeuroOne Medical Technologies Corporation - Common Stock?
The ticker symbol for NeuroOne Medical Technologies Corporation - Common Stock is NMTC on the Nasdaq Stock Market
What is the current price of NeuroOne Medical Technologies Corporation - Common Stock?
The current price of NeuroOne Medical Technologies Corporation - Common Stock is 0.7153
When was NeuroOne Medical Technologies Corporation - Common Stock last traded?
The last trade of NeuroOne Medical Technologies Corporation - Common Stock was at 02/24/26 09:56 AM ET
What is the market capitalization of NeuroOne Medical Technologies Corporation - Common Stock?
The market capitalization of NeuroOne Medical Technologies Corporation - Common Stock is 8.58M
How many shares of NeuroOne Medical Technologies Corporation - Common Stock are outstanding?
NeuroOne Medical Technologies Corporation - Common Stock has 9M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.